Fig. 5

Immunogenicity of recurrent oncogenic missense mutations in pediatric cancer. Somatic missense mutations occurring in tumors from three or more patients were included. Dark gray shows the number of samples with the SNV predicted as neoepitopes. Light gray indicates the number of samples with no predicted neoepitopes